This work also raises intriguing questions about whether BRCA2-heterozygous mammary epithelial cells in mutation carriers, which have been shown to be haploinsufficient for replication stress suppression126,127, may engage this self-reinforcing A3B loop early during tumorigenesis, thereby contributing to tumor evolution. The gene discussed is BRCA2; the disease is neoplasm.